Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Mant

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Blood|June 26, 2008
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progenyBrian J Taylor, Jitra Kriangkum, Julie A Pittman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequencesJitra Kriangkum, Brian J Taylor, Steven P Treon, et al.
Clinical Lymphoma|March 30, 2005
Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemiaSophia Adamia, Steven P Treon, Tony Reiman, et al.
Cancer Nursing|June 20, 2006
Understanding the determinants of exercise intentions in multiple myeloma cancer survivors: an application of the theory of planned behaviorLee W Jones, Kerry S Courneya, Jeffrey K H Vallance, et al.
Blood|October 24, 2002
In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expressionJonathan J Keats, Tony Reiman, Christopher A Maxwell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2004
Association between exercise and quality of life in multiple myeloma cancer survivorsLee W Jones, Kerry S Courneya, Jeffrey K H Vallance, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCsBrian J Taylor, Tony Reiman, Julie A Pittman, et al.
Plos One|June 21, 2014
Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancerHemalatha Kuppusamy, Helga M Ogmundsdottir, Eva Baigorri, et al.
Blood|January 29, 2005
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patientsJonathan J Keats, Christopher A Maxwell, Brian J Taylor, et al.
Blood|September 26, 2008
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemiaSophia Adamia, Amanda A Reichert, Hemalatha Kuppusamy, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood|June 26, 2008
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progenyBrian J Taylor, Jitra Kriangkum, Julie A Pittman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequencesJitra Kriangkum, Brian J Taylor, Steven P Treon, et al.
Clinical Lymphoma|March 30, 2005
Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemiaSophia Adamia, Steven P Treon, Tony Reiman, et al.
Cancer Nursing|June 20, 2006
Understanding the determinants of exercise intentions in multiple myeloma cancer survivors: an application of the theory of planned behaviorLee W Jones, Kerry S Courneya, Jeffrey K H Vallance, et al.
Blood|October 24, 2002
In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expressionJonathan J Keats, Tony Reiman, Christopher A Maxwell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2004
Association between exercise and quality of life in multiple myeloma cancer survivorsLee W Jones, Kerry S Courneya, Jeffrey K H Vallance, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCsBrian J Taylor, Tony Reiman, Julie A Pittman, et al.
Plos One|June 21, 2014
Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancerHemalatha Kuppusamy, Helga M Ogmundsdottir, Eva Baigorri, et al.
Blood|January 29, 2005
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patientsJonathan J Keats, Christopher A Maxwell, Brian J Taylor, et al.
Blood|September 26, 2008
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemiaSophia Adamia, Amanda A Reichert, Hemalatha Kuppusamy, et al.
Pageof 2